Coya Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-0.916; its P/E ratio is -8.96; Coya Therapeutics, Inc. is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 6.00M	-	-	-	$ 0.00
Gross Profit	$ 6.00M	-	-	-	-
EBIT	$ 1.29M	$ -3.42M	$ -2.40M	$ -2.74M	$ -2.00M
EBITDA	$ 1.30M	$ -3.42M	$ -2.39M	$ -2.73M	$ -2.00M
Net Income Common Stockholders	$ 1.27M	$ -3.42M	$ -3.10M	$ -2.74M	$ -4.45M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 32.60M	$ 10.89M	$ 13.10M	$ 16.32M	$ 5.93M
Total Assets	$ 41.26M	$ 11.90M	$ 14.47M	$ 17.42M	$ 8.40M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 12.97M
Net Debt	$ -32.60M	$ -10.89M	$ -13.10M	$ -16.32M	$ 7.03M
Total Liabilities	$ 5.63M	$ 1.81M	$ 1.22M	$ 1.27M	$ 16.79M
Stockholders Equity	$ 35.64M	$ 10.09M	$ 13.25M	$ 16.15M	$ -8.39M
Cash Flow	-
Free Cash Flow	$ -2.24M	$ -2.22M	$ -2.87M	$ -3.86M	$ -2.22M
Operating Cash Flow	$ -2.24M	$ -2.22M	$ -2.87M	$ -3.86M	$ -2.22M
Investing Cash Flow	$ -193.19K	-	$ -350.00K	-	$ -390.00K
Financing Cash Flow	$ 24.17M	-	-	$ 14.25M	$ -104.07K

Currency in USD

Coya Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Coya Therapeutics, Inc. Debt to Assets

Balance Sheet >

Coya Therapeutics, Inc. Cash Flow

Cash Flow >

Coya Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing